Skip to main content
Equibles

AETN · Aeternum Health, Inc.

Track AETN — free

Use AETN with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research AETN.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$2.08 -0.25 (-10.73%) At close · Oct 22
Rebalance outlook locked
Going-concern doubt — flagged Aug 19, 2026

Substantial doubt about the company's ability to continue as a going concern.

“These conditions raise substantial doubt about the Company's ability to continue as a going concern for a period of one year from the date these unaudited condensed financial statements are issued.”
View the 10-Q filed Aug 19, 2026
Market Cap
$11.31M
Shares
4.86M
Volume · Oct 22 467 Avg daily vol (12 sessions) 2283

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$2.08 Open$2.08 Day$2.08–2.14 Available close range$1.01–3.76 Avg vol 30d3K Short int19 · 0.0% float · 1.0d Short vol9% DataJul 2026–Oct 2026 Filing10-Q · Aug 19

The closing range uses available history since Jul 17, 2026; less than a full year is stored.

Up next

Latest filing: 10-Q
filed Aug 19, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$41,258
Trailing 12 months
Net income (TTM)
$1.35M
Trailing 12 months
Revenue growth YoY
-98.6%
Year over year
Operating margin
-132.2%
Trailing 12 months
P / E (TTM)
11.7
Trailing earnings · reciprocal yield 8.6%
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
−$2.27M
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+11.1%
Year over year · more shares
Price change (1Y)
—
Trailing year
Short interest
—
Latest settlement
View all 122 metrics

Quarterly results

Revenue Net income Net loss
▲412.8% $33,361 −$116,283 '24 Q2 ▲52.5% $15,442 −$77,195 '24 Q3 ▲2762.4% $12,480 −$139,313 '24 Q4* ▲4190.2% $164,657 $5,891 '25 Q1 ▼78.7% $7,122 −$105,855 '25 Q2 ▼46% $8,345 −$137,860 '25 Q3 ▲88.5% $23,531 −$99,270 '25 Q4* LATEST ▼98.6% $2,260 −$139,655 '26 Q1

* Q4 derived as the full year minus Q1 to Q3.

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Sell Momentum Limited Sentiment Neutral Fundamentals Limited Quant / Vol Very High
Market backdrop VIX 19 · elevated Equity put/call 0.69
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 50-day avg −21%
below
RSI (14) 46
neutral
MACD trend Negative
52-week position 39%
mid-range
Volume (OBV) Bullish div.
accumulating
Momentum
relative strength
Limited
Not enough data for a confident read.
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50/200-day averages unavailable
Institutional flow Flat
No 13F holder data
Insider flow Flat
No net insider activity over 90 days
Short interest Flat
0.00% of float · ▬ 0.0% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
No 13F holder history
Fundamentals
Limited
Not enough data for a confident read.
Quant / Vol
risk profile
Very High
Volatility 509%
annualized · 1-yr
Max drawdown −73%
past year
ATR 30.3%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Sell
2 · 3 · 1
50 / 200-day cross
No cross Neutral
Price vs 50-day avg
−21% Bearish
RSI (14)
46 Neutral
MACD trend
Negative Bearish
52-week position
39% Neutral
Volume (OBV)
Bullish div. Bullish
Market signals — smart money & positioning
No clear signal
Trend (MA cross) No cross
50/200-day averages unavailable
Institutional flow Flat
No 13F holder data
Insider flow Flat
No net insider activity over 90 days
Short interest Flat
0.00% of float · ▬ 0.0% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
No 13F holder history
Price context
position in its available closing range
Range low $1 Now $2 · 39% Range high $4
vs 50-day avg -21%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

KPI extraction has been attempted, but no publishable series is available from the examined filings. This is not evidence that the company reports no KPIs.

Versus peers

Other Industrial Metals & Mining — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
AETN
Aeternum Health, Inc.
this stock
$11.31M — +212.7% — 0.0%
BHP
BHP Group Ltd
 $197.17B +28.5% — — 0.8%
RTNTF
Rio Tinto Ltd
 $182.64B +1.3% — — 0.0%
RIO
Rio Tinto PLC
 $136.84B +5.1% — — 0.6%
GLCNF
Glencore plc
 $87.57B +33.6% — — 0.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Short & Settlement
Short Interest
Shares short
19
Days to cover
1.0d
Change
0 sh
View
Short Volume
Short vol %
9%
As of
Oct 22, 2026
Short Total
View
Fails to Deliver
FTD shares
11
Value
$2
As of
Sep 4, 2026
View
Off-Exchange
Off-exchange %
100.0%
Week of
Sep 14, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$203.7K
Net income (FY)
$-337.1K
EPS diluted
$-0.20
View
Filings
SEC Filings
Latest
8-K
Filed
Sep 25, 2026
This year
10
View

Performance

5D 20D 120D MTD YTD
AETN -20.0% -5.5% — -30.6% —
SPY -1.0% -0.4% +6.0% +0.2% +12.0%
vs SPY -19.0% -5.0% — -30.7% —
Key facts CIK 764630 CUSIP 911634103 Visit website Investor relations